AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 173 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,451,000 | -36.7% | 142,800 | -49.6% | 0.06% | -38.4% |
| Q3 2019 | $5,450,000 | +21.5% | 283,535 | +86.7% | 0.10% | +25.3% |
| Q2 2019 | $4,487,000 | -38.1% | 151,855 | -0.6% | 0.08% | -39.2% |
| Q1 2019 | $7,254,000 | +15.6% | 152,710 | -12.1% | 0.13% | +4.0% |
| Q4 2018 | $6,273,000 | -38.0% | 173,760 | +5.6% | 0.12% | -22.4% |
| Q3 2018 | $10,123,000 | – | 164,475 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |